- Voyager Therapeutics: FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation for Voyager's VY-AADC gene therapy treatment for Parkinson's disease in patients with motor fluctuations that are refractory to medical management
Thursday, June 21, 2018
====Voyager Therapeutics (VYGR) : RMAT designation for Parkinson's disease treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment